Dr. Arash Fazl, MD, PhD

Dr. Fazl practices at EvergreenHealth Medical Center Kirkland in Kirkland, Washington.

Dr. Fazl's NPI, 1780973800, was assigned on March 29, 2011. Dr. Fazl holds Washington license MD.MD.61222778.

Dr. Fazl's primary practice is EvergreenHealth Medical Center Kirkland, at 12040 Ne 128th St, Kirkland, WA 98034 in King County. The practice phone is (425) 899-1000.

Dr. Fazl's primary practice is EvergreenHealth Medical Center Kirkland in Kirkland, Washington. Dr. Fazl is also affiliated with EvergreenHealth Medical Center. The medical group on file is Select Rehabilitation. Dmand AI also links Dr. Fazl to 2 more hospitals, 3 medical groups, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fazl practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Fazl's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Fazl's licenses on file in 2 states: Washington and New York.

CMS data shows 1,156 Medicare services from Dr. Fazl across 9 procedure codes in 2024, for 325 Medicare patients. Medicare paid $61,345 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 325 Medicare patients who saw Dr. Fazl in 2024. The largest group is 75 to 84, with 153 patients. 74% of them have parkinson's disease, and 68% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fazl's median patient age at 76, with 42% women.

In 2024, Dr. Fazl wrote 3,145 Medicare Part D claims for 483 patients. 88% of them were for generic drugs. CMS names the drug for 2,910 of them, across 40 drugs with 11 or more claims each, at $1,082,238 in total drug cost. In 2023, CMS named 2,013 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Fazl for performance year 2024, reported through an alternative payment model (APM). Dr. Fazl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fazl as offering telehealth.

Dmand AI links 5 papers to Dr. Fazl, published from 2017 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Basal Ganglia, Deep Brain Stimulation and Parkinson Disease. Dr. Fazl's most frequent co-authors are Alon Y. Mogilner, MD, Michael H. Pourfar, MD and William Barbosa, MD.

CMS Open Payments shows 474 general payments to Dr. Fazl from 53 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $36,170.